{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:24:44Z","timestamp":1791343484683,"version":"4.3.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2,6]]},"DOI":"10.1093\/jnci\/djm328","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T05:18:52Z","timestamp":1201670332000},"page":"184-198","source":"Crossref","is-referenced-by-count":294,"title":["Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia"],"prefix":"10.1093","volume":"100","author":[{"given":"Weiguo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Konopleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-xi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"McQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeev","family":"Estrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Quint\u00e1s-Cardama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Andreeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,2,6]]},"reference":[{"issue":"5","key":"key\n\t\t\t\t20170702073912_bib1","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"issue":"12","key":"key\n\t\t\t\t20170702073912_bib2","first-page":"1911","article-title":"Internal tandem duplication of the flt3 gene found in acute myeloid leukemia","volume":"10","author":"Nakao","year":"1996","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170702073912_bib3","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2007-08-107946","article-title":"FLT3 D835\/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications [published online ahead of print Oct 16, 2007]","author":"Whitman","year":"2007","journal-title":"Blood"},{"issue":"5","key":"key\n\t\t\t\t20170702073912_bib4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.onc.1203354","article-title":"Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines","volume":"19","author":"Hayakawa","year":"2000","journal-title":"Oncogene"},{"issue":"9","key":"key\n\t\t\t\t20170702073912_bib5","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.leu.2403859","article-title":"Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia","volume":"19","author":"Ricciardi","year":"2005","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170702073912_bib6","first-page":"716a","article-title":"ERK2 and phospho-ERK2 are prognostic for survival in AML and complement the prognostic impact of Bax and BCL-2 [abstract 2991]","volume":"98S","author":"Kornblau","year":"2001","journal-title":"Blood"},{"issue":"10","key":"key\n\t\t\t\t20170702073912_bib7","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2003-11-3775","article-title":"Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia","volume":"103","author":"Smith","year":"2004","journal-title":"Blood"},{"issue":"2","key":"key\n\t\t\t\t20170702073912_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2004-05-1902","article-title":"Internal tandem duplications of the FLT3 gene are present in leukemia stem cells","volume":"106","author":"Levis","year":"2005","journal-title":"Blood"},{"issue":"3","key":"key\n\t\t\t\t20170702073912_bib9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood-2004-05-1846","article-title":"A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease","volume":"105","author":"Fiedler","year":"2005","journal-title":"Blood"},{"issue":"10","key":"key\n\t\t\t\t20170702073912_bib10","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.leu.2402674","article-title":"Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor","volume":"16","author":"Tse","year":"2002","journal-title":"Leukemia"},{"issue":"5","key":"key\n\t\t\t\t20170702073912_bib11","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2006-05-024679","article-title":"MEK blockade converts AML differentiating response to retinoids into extensive apoptosis","volume":"109","author":"Milella","year":"2007","journal-title":"Blood"},{"issue":"6","key":"key\n\t\t\t\t20170702073912_bib12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/sj.leu.2404213","article-title":"Phase 1 study of PTK787\/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome","volume":"20","author":"Roboz","year":"2006","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170702073912_bib13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0076-6879(05)07047-3","article-title":"Wilhelm SM.Sorafenib (BAY 43-9006, Nexavar((R))), a dual-action inhibitor that targets RAF\/MEK\/ERK pathway in tumor cells and tyrosine kinases VEGFR\/PDGFR in tumor vasculature","volume":"407","author":"Adnane","year":"2005","journal-title":"Methods Enzymol"},{"issue":"19","key":"key\n\t\t\t\t20170702073912_bib14","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"issue":"10","key":"key\n\t\t\t\t20170702073912_bib15","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.leu.2402674","article-title":"Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor","volume":"16","author":"Tse","year":"2002","journal-title":"Leukemia"},{"issue":"1","key":"key\n\t\t\t\t20170702073912_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1097-0320(20000501)40:1<19::AID-CYTO3>3.0.CO;2-3","article-title":"Cell-surface exposure of phosphatidylserine correlates with the stage of fludarabine-induced apoptosis in chronic lymphocytic leukemia (CLL) and expression of apoptosis-regulating genes","volume":"40","author":"Clodi","year":"2000","journal-title":"Cytometry"},{"issue":"11","key":"key\n\t\t\t\t20170702073912_bib17","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2403929","article-title":"Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation","volume":"19","author":"Zhang","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"key\n\t\t\t\t20170702073912_bib18","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1158\/0008-5472.CAN-06-3629","article-title":"The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling","volume":"67","author":"Ling","year":"2007","journal-title":"Cancer Res."},{"issue":"3","key":"key\n\t\t\t\t20170702073912_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1309\/5DGB59KQA527PD47","article-title":"Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations","volume":"122","author":"Oyarzo","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"key\n\t\t\t\t20170702073912_bib20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2141.2005.05666.x","article-title":"Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type","volume":"130","author":"Chen","year":"2005","journal-title":"Br J Haematol"},{"issue":"12","key":"key\n\t\t\t\t20170702073912_bib21","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1182\/blood.V86.12.4594.bloodjournal86124594","article-title":"Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation","volume":"86","author":"Estrov","year":"1995","journal-title":"Blood"},{"issue":"21","key":"key\n\t\t\t\t20170702073912_bib22","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1158\/0008-5472.CAN-03-2402","article-title":"The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia","volume":"64","author":"Konopleva","year":"2004","journal-title":"Cancer Res."},{"issue":"9","key":"key\n\t\t\t\t20170702073912_bib23","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.leu.2403859","article-title":"Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia","volume":"19","author":"Ricciardi","year":"2005","journal-title":"Leukemia"},{"issue":"24","key":"key\n\t\t\t\t20170702073912_bib24","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"issue":"23","key":"key\n\t\t\t\t20170702073912_bib25","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1158\/1078-0432.CCR-04-1087","article-title":"Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses","volume":"10","author":"Zhao","year":"2004","journal-title":"Clin Cancer Res."},{"issue":"5","key":"key\n\t\t\t\t20170702073912_bib26","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/1078-0432.CCR-0914-3","article-title":"VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein","volume":"10","author":"Minderman","year":"2004","journal-title":"Clin Cancer Res."},{"key":"key\n\t\t\t\t20170702073912_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"key\n\t\t\t\t20170702073912_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"issue":"4","key":"key\n\t\t\t\t20170702073912_bib29","first-page":"815","article-title":"Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene","volume":"8","author":"Lyman","year":"1993","journal-title":"Oncogene"},{"issue":"4","key":"key\n\t\t\t\t20170702073912_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"issue":"25","key":"key\n\t\t\t\t20170702073912_bib31","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2174\/1381612023393125","article-title":"Design and discovery of small molecules targeting raf-1 kinase","volume":"8","author":"Lowinger","year":"2002","journal-title":"Curr Pharm Des"},{"issue":"11","key":"key\n\t\t\t\t20170702073912_bib32","doi-asserted-by":"crossref","first-page":"941a","DOI":"10.1182\/blood.V106.11.3367.3367","article-title":"Raf Inhibitor BAY 43-9006 induces Bim dephosphorylation and activates the intracellular apoptotic pathway in AML","volume":"106","author":"Zhang","year":"2005","journal-title":"Blood"},{"issue":"42","key":"key\n\t\t\t\t20170702073912_bib33","doi-asserted-by":"crossref","first-page":"35217","DOI":"10.1074\/jbc.M506551200","article-title":"Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation","volume":"280","author":"Rahmani","year":"2005","journal-title":"J Biol Chem."},{"issue":"11","key":"key\n\t\t\t\t20170702073912_bib34","first-page":"149a","article-title":"Sorafenib (BAY 43-9006) directly targets FLT3-ITD in acute myelogenous leukemia [abstract 255]","volume":"108","author":"Zhang","year":"2006","journal-title":"Blood"},{"issue":"3","key":"key\n\t\t\t\t20170702073912_bib35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.leu.2404508","article-title":"Antitumor activity of sorafenib in FLT3-driven leukemic cells","volume":"21","author":"Auclair","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"key\n\t\t\t\t20170702073912_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3324\/haematol.10692","article-title":"The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors","volume":"92","author":"Lierman","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"key\n\t\t\t\t20170702073912_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0960-9822(00)00310-9","article-title":"Rsk1 mediates a MEK-MAP kinase cell survival signal","volume":"10","author":"Shimamura","year":"2000","journal-title":"Curr Biol."},{"issue":"4","key":"key\n\t\t\t\t20170702073912_bib38","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1073\/pnas.97.4.1578","article-title":"Survival function of ERK1\/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases","volume":"97","author":"Deng","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5338","key":"key\n\t\t\t\t20170702073912_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.278.5338.687","article-title":"Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt","volume":"278","author":"Del Peso","year":"1997","journal-title":"Science"},{"issue":"3","key":"key\n\t\t\t\t20170702073912_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.cdd.4400492","article-title":"Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells","volume":"6","author":"Leverrier","year":"1999","journal-title":"Cell Death Differ"},{"issue":"29","key":"key\n\t\t\t\t20170702073912_bib41","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1038\/sj.onc.1202796","article-title":"IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line","volume":"18","author":"Dumon","year":"1999","journal-title":"Oncogene"},{"issue":"11","key":"key\n\t\t\t\t20170702073912_bib42","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1182\/blood.V99.11.3885","article-title":"A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo","volume":"99","author":"Levis","year":"2002","journal-title":"Blood"},{"issue":"1","key":"key\n\t\t\t\t20170702073912_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood-2004-03-0891","article-title":"Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412","volume":"105","author":"Stone","year":"2005","journal-title":"Blood"},{"issue":"6","key":"key\n\t\t\t\t20170702073912_bib44","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2003-05-1653","article-title":"Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoietic cells","volume":"103","author":"Bagrintseva","year":"2004","journal-title":"Blood"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/100\/3\/184\/18074623\/djm328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T08:51:27Z","timestamp":1588323087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djm328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,6]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,2,6]]},"published-print":{"date-parts":[[2008,2,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djm328","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,6]]}}}